SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Intellectus Partners LLC

Intellectus Partners LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 11,164 shares of the exchange traded fund’s stock after acquiring an additional 425 shares during the period. Intellectus Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,005,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $141,284,000. Proficio Capital Partners LLC increased its stake in SPDR S&P Biotech ETF by 16,156.1% during the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after buying an additional 911,686 shares during the period. Raymond James Financial Inc. purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $55,529,000. Finally, Assetmark Inc. lifted its holdings in SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $87.30 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a market capitalization of $5.76 billion, a PE ratio of 11.47 and a beta of 0.93. The business has a 50-day moving average of $90.57 and a 200-day moving average of $95.46.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.